The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia

被引:2
|
作者
Fernando, Fiona [1 ,2 ]
Innes, Andrew J. [1 ,2 ]
Claudiani, Simone [1 ,2 ]
Pryce, Angharad [1 ,2 ]
Hayden, Chloe [3 ]
Byrne, Jenny [4 ]
Gallipoli, Paolo [5 ]
Copland, Mhairi [6 ]
Apperley, Jane F. [1 ,2 ]
Milojkovic, Dragana [1 ,2 ]
机构
[1] Imperial Coll London, Ctr Haematol, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept Clin Haematol, London, England
[3] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, North West London Pathol, London, England
[4] Nottingham Univ Hosp NHS Trust, Ctr Clin Haematol, Nottingham, England
[5] Queen Mary Univ London, Barts Canc Inst, Ctr Haemato Oncol, London, England
[6] Univ Glasgow, Paul OGorman Leukaemia Res Ctr, Sch Canc Sci, Glasgow, Scotland
关键词
HEMATOPOIETIC-CELL TRANSPLANTATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; RELAPSE;
D O I
10.1038/s41409-023-01975-9
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:826 / 828
页数:3
相关论文
共 50 条
  • [21] Pre-Transplant Therapy for Patients with Myelodysplastic Syndrome and Post-Transplant Outcome
    Farhan, Shatha
    McKinnon, Rick
    Szymanski, Sarah
    Neme, Klodiana
    Mikulandric, Nancy
    Peres, Edward
    Janakiraman, Nalini
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S288 - S288
  • [22] Late post-transplant recurrence of Chronic Myeloid Leukaemia after immuno-chemotherapy for secondary Non-Hodgkin's Lymphoma
    Orlandi, Ester M.
    Colombo, Anna A.
    Rocca, Barbara
    LEUKEMIA RESEARCH, 2011, 35 (06) : E73 - E74
  • [23] Clinical outcomes of chronic myeloid leukaemia patients taking asciminib through a Managed Access Programme (MAP) in Australia
    Chee, Lynette
    Lee, Nora
    Grigg, Andrew
    Chen, Melissa
    Schwarer, Anthony
    Szer, Jeff
    Ratnasingam, Sumita
    Raj, Sonia
    Lukito, Pohan
    Yeung, David
    Hughes, Timothy
    Shanmuganathan, Naranie
    INTERNAL MEDICINE JOURNAL, 2024, 54 (07) : 1214 - 1218
  • [24] Clinical Outcomes of Chronic Myeloid Leukaemia (CML) Patients on Asciminib through the Managed Access Program (MAP) in Australia
    Chee, Lynette C. Y.
    Lee, Nora
    Grigg, Andrew
    Chen, Melissa
    Schwarer, Anthony
    Szer, Jeff
    Yeung, David T.
    Hughes, Timothy
    Shanmuganathan, Naranie
    BLOOD, 2022, 140 : 6800 - 6802
  • [25] Effect of KIR genotype on outcome of patients with chronic myeloid leukaemia undergoing HLA identical stem cell transplant
    Mathews, V
    Sellathamby, S
    K, ML
    George, B
    Ramachandra, S
    Chandy, VM
    Srivastava, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S211 - S211
  • [26] Post-transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high-risk acute myeloid leukaemia
    Oshikawa, Gaku
    Kakihana, Kazuhiko
    Saito, Makoto
    Aoki, Jun
    Najima, Yuho
    Kobayashi, Takeshi
    Doki, Noriko
    Sakamaki, Hisashi
    Ohashi, Kazuteru
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (05) : 756 - 759
  • [27] IMATINIB AND ITS CLINICAL ASSOCIATED OUTCOME IN CHRONIC MYELOID LEUKAEMIA PATIENTS
    Singh, A. K.
    Vidyadhari, A.
    VALUE IN HEALTH, 2020, 23 : S29 - S29
  • [28] Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices
    Yin, Michael Yaoyao
    Wever-Pinzon, Omar
    Mehra, Mandeep R.
    Selzman, Craig H.
    Toll, Alice E.
    Cherikh, Wida S.
    Nativi-Nicolau, Jose
    Fang, James C.
    Kfoury, Abdallah G.
    Gilbert, Edward M.
    Kemeyou, Line
    McKellar, Stephen H.
    Koliopoulou, Antigone
    Vaduganathan, Muthiah
    Drakos, Stavros G.
    Stehlik, Josef
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (08): : 858 - 869
  • [29] Clinical Outcome of 96 Post-Transplant Lymphoproliferative Disease Patients in a Renal Transplant Cohort
    Damasco Penna, Adriana M.
    Garibaldi Junior, Joao
    Perini, Guilherme Fleury
    Cavalcanti, Egyla M.
    Cristelli, Marina P.
    Bruscato, Adriana
    Medina Pestana, Jose Osmar
    Colleoni, Gisele W. B.
    Zampieri Filho, Jose Pedro
    Vaez, Rodrigo
    Baiocchi, Otavio C. G.
    Bordin, Jose Orlando
    BLOOD, 2015, 126 (23)
  • [30] ASCIMINIB, A NEW THERAPEUTIC OPTION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Garcia-Gutierrez, V
    Boque Genovard, C.
    Velez Tenza, P.
    Giraldo, P.
    Ramirez, M. J.
    Alonso-Dominguez, J. M.
    Jimenez Velasco, A.
    de Abia, Luna A.
    Hernadez-Boluda, J. C.
    HAEMATOLOGICA, 2019, 104 : 302 - 303